Angioedema associated with thrombolysis for ischemic stroke: analysis of a case-control study

Autor: O. Fain, Denis Sablot, C. Héroum, Thomas Ronzière, M. Gaudron, S. Di Legge, A. Lecluse, Olivier Detante, F. Dumont, S. Marcel, Sonia Alamowitch, D. Gobert, Isabelle Boccon-Gibod, Guillaume Marc, D. Smadja, Michael Obadia, D. Launay, S. Lefèvre, M. Sévin, Laurence Bouillet, Laurent Suissa, Stéphane Gayet, M. B. Vlaicu, Emilie Doche, Clara Vigneron, Nicolas Javaud, Igor Sibon, I. Ion, I. Arnaud, P. Girard‐Madoux
Rok vydání: 2019
Předmět:
Zdroj: Journal of internal medicineReferences. 286(6)
ISSN: 1365-2796
Popis: BACKGROUND Bradykinin-mediated angioedema (AE) is a complication associated with thrombolysis for acute ischemic stroke. Risk factors are unknown and management is discussed. OBJECTIVES To clarify risk factors associated with bradykinin-mediated AE after thrombolysis for acute ischemic stroke. METHODS In a case-control study conducted at a French reference centre for bradykinin angiœdema, patients with thrombolysis for acute ischemic stroke and a diagnosis of bradykinin-mediated angiœdema, were compared to controls treated with thrombolysis treatment without angiœdema. RESULTS Fifty-three thrombolysis-related AE were matched to 106 control subjects. The sites of attacks following thrombolysis for ischemic stroke mainly included tongue (34/53, 64%) and lips (26/53, 49%). The upper airways were involved in 37 (70%) cases. Three patients required mechanical ventilation. Patients with bradykinin-mediated angiœdema were more frequently women [33 (62%) vs. 44 (42%); P = 0.01], had higher frequency of prior ischemic stroke [12 (23%) vs. 9 (8%); P = 0.01], hypertension [46 (87%) vs. 70 (66%); P = 0.005], were more frequently treated with angiotensin-converting enzyme inhibitor [37 (70%) vs. 28 (26%); P
Databáze: OpenAIRE